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The pre-B cell receptor (pre-BCR), composed
of immunoglobulin m heavy chain and the surro-
gate light chain (SLC) proteins l5 and Vpreb,
signals for proliferation and maturation of de-
veloping pre-B cells. It has been assumed that
pre-B cells stop cycling by the pre-BCR-medi-
ated downregulation of SLC transcription. We
generated transgenic mice expressing SLC
throughout B cell development and, remark-
ably, found that enforced SLC expression had
no effect on pre-B cell proliferation or differenti-
ation. However, in the presence of conventional
immunoglobulin light chains, SLC components
had the capacity to induce constitutive BCR
internalization, secondary immunoglobulin light-
chain rearrangement, and a severe develop-
mental arrest of immature B cells, dependent
on the adaptor protein Slp65. Residual B cells
in the spleen showed increased expression of
surface CD5, which is a negative regulator of
BCR signaling, and differentiated spontane-
ously into IgM+ plasma cells. Thus, the silenc-
ing of SLC genes is not essential for the
limitation of pre-B cell proliferation, but is
required for the prevention of constitutive
activation of B cells.
INTRODUCTION
B lymphocytes are generated in the bone marrow (BM) via
a stepwise process of the sequential expression of various
cell surface markers and the ordered rearrangement of
immunoglobulin heavy chain (Igh, IgHC) and k (Igk) or l
(Igl) light chain (LC) loci. At the pro-B cell stage, productive
Igh V(D)J rearrangement leads to surface expression of
the precursor-B cell receptor (pre-BCR), composed of
a mHC (Igh-6) and the nonrearranging l5 (Igll1, CD179b)
and Vpreb (CD179a) surrogate light chain (SLC) compo-
nents (Karasuyama et al., 1990; Kudo and Melchers,468 Immunity 27, 468–480, September 2007 ª2007 Elsevier Inc1987; Sakaguchi and Melchers, 1986; Tsubata and Reth,
1990). The pre-BCR is a key checkpoint in B cell develop-
ment that monitors the assembly of functional mHC. Pre-
BCR signaling induces the clonal expansion of mHC+
pre-B cells, whereby interleukin-7 (IL-7) functions as a
crucial pre-B cell proliferation factor in the mouse
(Hendriks and Middendorp, 2004; Kitamura et al., 1992;
Melchers, 2005). The resulting large cycling pre-B cells
terminate further Igh rearrangement to ensure allelic
exclusion. In addition, pre-BCR signaling terminates the
transcription of the genes encoding l5 and Vpreb (Flem-
ming et al., 2003; Meixlsperger et al., 2007; Middendorp
et al., 2002; Parker et al., 2005), which are closely linked
and coordinately regulated by a locus control region (Sab-
battini and Dillon, 2005). It has been hypothesized that
proliferating pre-B cells become resting when SLCs are
diluted out, thereby limiting pre-BCR expression (Melch-
ers, 2005). Subsequent differentiation into small resting
pre-B cells results in the rearrangement of Igk or Igl gene
loci and changes in cell-surface-marker profiles: CD43
and IL-7R expression are terminated, and CD2, CD25,
and major histocompatibility complex (MHC) class II are
induced (Hendriks and Middendorp, 2004). Successful
Ig LC gene rearrangement leads to BCR expression, and
additional checkpoints followwhen the resulting immature
B cells progress to mature B cells.
The Vpreb protein, encoded by the two highly homolo-
gous Vpreb1 and Vpreb2 genes, of which Vpreb1 is mainly
utilized (Mundt et al., 2006), contains segments homolo-
gous to conventional IgLC variable regions (Kudo and
Melchers, 1987; Melchers, 2005; Sakaguchi and Melch-
ers, 1986). The l5 protein contains a domain that is homol-
ogous to the lLC constant regions (Kudo and Melchers,
1987; Sakaguchi and Melchers, 1986) and is thought to
associate with the first constant region (CH1) of mHC to
form the pre-BCR. The targeted deletion of Igll1 (encoding
l5) or Vpreb, or the deficiency of the homologous IGLL1
(14.1) gene in humans, results in a severe B cell immuno-
deficiency due to defective pre-B cell proliferation (Kita-
mura et al., 1992; Minegishi et al., 1998; Mundt et al.,
2001). It has been shown that the non-Ig domain of l5
mediates cell-autonomous pre-BCR signaling, resulting
in constitutive pre-BCR internalization, Iga phosphoryla-
tion, and Ca2+ flux (Meixlsperger et al., 2007; Ohnishi.
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linked by neighboring pre-BCR molecules or by a ligand
expressed on pre-B cells. Nevertheless, interactions be-
tween pre-BCR and stromal cell-derived galectin-1
(Lgals1) or between pre-B cell integrins and stromal li-
gands might contribute to pre-BCR signaling (Bradl and
Jack, 2001; Gauthier et al., 2002).
Pre-BCR activation induces Iga,Igb-phosphorylation
and lipid-raft formation containing phosphorylated tyro-
sine kinases Lyn, Syk, and Bruton’s tyrosine kinase (Btk)
and adaptor protein Slp65 (SH2 domain-containing leuko-
cyte-specific phosphoprotein of 65 kDa, or Bash, Blnk)
(Guo et al., 2000; Hendriks and Middendorp, 2004; Kouro
et al., 2001). It was recently shown that pre-BCR signaling,
via Slp65, induces the expression of the transcription
factors Irf4 and Aiolos (Ikzf3), which are required for the
efficient silencing of the Igll1-Vpreb locus (Thompson
et al., 2007). The deficiency of Btk or Slp65 results in
impaired pre-BCR downregulation, arrested pre-B cell
maturation, and increased proliferation of large pre-B cells
in IL-7-driven BM cultures (Flemming et al., 2003; Midden-
dorp et al., 2002). Moreover, Slp65-deficient mice sponta-
neously develop pre-B cell leukemia expressing high
amounts of surface pre-BCR (Flemming et al., 2003).
Btk-deficient mice do not develop tumors, but in
Slp65;Btk double-deficient mice, leukemia incidence is
significantly increased (Kersseboom et al., 2003).
Although it has been assumed that upon the silencing of
the Igll1-Vpreb locus, pre-B cells lose their proliferative
capacity because they have used up previously synthe-
sized SLC for pre-BCR formation, direct evidence for
this model is lacking (Hendriks and Middendorp, 2004;
Melchers, 2005). Thus, the contribution of SLC downregu-
lation to pre-B cell proliferation and developmental pro-
gression is unknown.
In this report, we investigated whether pre-BCR down-
regulation is absolutely required for the termination of pre-
B cell proliferation. Therefore, we generated transgenic
(Tg) mice expressing l5 and Vpreb1 proteins under the
control of the humanCD19 promoter region, which targets
the expression of transgenes to all stages of B cell devel-
opment. Remarkably, we found that Tg expression of the
SLC components had no effect on pre-B cell proliferation
or differentiation. However, the presence of SLC proteins
beyond the pre-B cell stage severely hampered B cell de-
velopment, resulting in constitutive B cell activation, asso-
ciated with increased receptor editing and deletion
of immature B cells and increased IgM+ plasma cell
differentiation. Collectively, these findings show that the
silencing of SLC genes is not essential for the limitation
of pre-B cell proliferation but is required for the prevention
of the constitutive activation of B cells.
RESULTS
Generation of SLC Tg Mice
To explore the effects of SLC expression beyond the large
pre-B cell stage, we generated Tg mice by using murine
Igll1 (the gene that encodes l5) and Vpreb1 genomicImconstructs that were individually ligated to a human
CD19 promoter fragment (Figure 1A). Two CD19-l5
(l5#1, l5#2) and four CD19-Vpreb Tg (Vpreb#1-Vpreb#4)
lines were generated, and l5;Vpreb double-Tg mice
were obtained by interbreeding. The mice used in this
study were high-copy-number l5#2;Vpreb#1 Tg mice or,
when specifically indicated, the lower-copy-number
l5#1;Vpreb#3 mice (Table S1 in the Supplemental Data
available online). SLC Tgmice did not exhibit any develop-
mental defects or tumor susceptibility for over 12 months
of age.
As assessed by intracellular flow cytometry, in wild-type
(WT) mice, SLC expression was restricted to pro-B and
large cycling pre-B cells (Figure 1B). In contrast, the
l5#2;Vpreb#1 mice manifested substantial SLC expres-
sion throughout B cell development, whereby expression
increased as B cells matured (Figure 1B). The lower-copy-
number l5#1;Vpreb#3 Tg mice expressed approximately
25% of the SLC amounts present in l5#2;Vpreb#1 mice
(Table S1).
In agreement with constitutive pre-BCR internalization
in pre-B cells, SLC expression on the surface of
l5#2;Vpreb#1 Tg pre-B cells was only slightly increased
when compared with WT pre-B cells (Figure 1C). Next,
we analyzed surface SLC expression, out of the context of
pre-B cells, in splenic membrane Igk+ B cells from l5#2,
Vpreb#1, and l5#2;Vpreb#1 mice (Figure 1D). Although
l5 surface expression was reported to be dependent on
the presence of Vpreb (Minegishi et al., 1999; Seidl et al.,
2001), l5 was detected on the surface of l5#2 Tg B cells.
Nevertheless, the concomitant presence of Tg Vpreb sub-
stantially increased surface l5 expression. Vpreb#1 Tg
splenic B cells had high surface Vpreb expression, in
line with the reported capacity of Vpreb to be expressed
on the surface without l5 (Minegishi et al., 1999; Seidl
et al., 2001). However, Vpreb expression also increased
when l5 was coexpressed. High expression of SLC pro-
teins was observed on the surface of l5#2;Vpreb#1 Tg
splenic B cells, indicating that pre-BCRs are not efficiently
internalized in Igk+ splenic B cells (Figure 1D). Thus, in the
l5#2;Vpreb#1 Tg mice, mature splenic B cells coex-
pressed pre-BCR and BCR on the cell surface.
Enforced SLC Expression Interferes
with B Cell Development
Flow cytometry was used so that the effects of enforced
SLC expression on B cell development in l5#2, Vpreb#1
and double-Tg mice could be determined (Figure 2A and
2B). In BM, the size of the B220lowIgm pro-;pre-B cell
compartment was not significantly different between the
four groups of mice. In contrast, in Vpreb#1 and
l5#2;Vpreb#1 mice, B220lowIgm+ immature B cells were
decreased in number andmanifested reduced Igm expres-
sion. In SLC single- or double-Tg mice, recirculating
B220highIgm+ B cells were almost completely absent.
Accordingly, in the spleen and particularly in the mesen-
teric lymph nodes of thesemice, the proportions ofmature
B cells were significantly reduced (Figure 2A). In the peri-
toneal cavity of SLC Tgmice, the proportion of CD5+ B-1 Bmunity 27, 468–480, September 2007 ª2007 Elsevier Inc. 469
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SLC Silencing Avoids Autonomous B Cell ActivationFigure 1. Structure and Expression of CD19-l5 and CD19-Vpreb Transgenes
(A) Map of themouse Igll1-Vpreb1 locus and the CD19-l5 andCD19-Vpreb Tg constructs. Exons of Igll1 (encoding l5) and Vpreb1 genes (pointed out
by numbers) are indicated.
(B) Cytoplasmic (c) l5 (Igll1) and Vpreb expression in the indicated B lineage cell populations fromWT and l5#2;Vpreb#1 Tg mice. Pro-B (CD19+cm-),
large pre-B (CD19+cm+CD2-), small pre-B (CD19+ck-CD2+), immature B (CD19+ck+) fractions from BM, and mature B (CD19+ck+) fractions from
spleen were gated and analyzed for intracellular expression of SLC components.
(C) Flow cytometric analysis of mebrane l5 and Vpreb expression on CD19+ck- pre-B cells from WT and l5#2;Vpreb#1 mice.
(D) Examination of membrane expression of l5 and Vpreb on gated CD19+ splenic B cells from WT mice and SLC Tg mice. Results are displayed as
histogram overlays. Coexpression of kLC and SLC components is shown at the bottom as dot plots. The percentages of cells within the indicated
quadrants are given. Plots are representative for four mice of each genotype.cells was increased. In summary, the enforced expression
of either one or both SLC components interfered with
B cell development, predominantly affecting the BCR+
compartments.
Normal Differentiation of SLC Tg Pre-B Cells
Because SLC expression is normally terminated at the
transition of large cycling into small resting pre-B cells,
we investigated the developmental progression of SLC
Tg pre-B cells. We found that enforced SLC expression470 Immunity 27, 468–480, September 2007 ª2007 Elsevier Incdid not substantially affect the pre-BCR-induced upregu-
lation of CD2, CD25, and MHC class II or the downregula-
tion of CD43 and IL-7R in cytoplasmic m+k pre-B cells
(Figure 3A and data not shown).
So that the effect of enforced SLC expression on the
proliferation of developing B-lineage cells in vivo could
be determined, WT and l5#2;Vpreb#1 mice were pulsed
with a single dose of the thymidine analog 5-bromodeoxy-
uridine (BrdU), which is normally selectively incorporated
into the DNA of large pre-B cells (Middendorp et al., 2002)..
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large pre-B cell fractions of WT and l5#2;Vpreb#1 mice
(Figure 3B) and found no induction of BrdU incorporation
in small pre-B or immature B cells of l5#2;Vpreb#1 mice.
Because a possibility remained that the amount of SLC
expression achieved in l5#2;Vpreb#1 Tg pre-B cells
(Figure 1B) was too low to increase their proliferative
capacity, we bred l5#2;Vpreb#1 Tg mice to homozygos-
ity. The obtained homozygous l5#2;Vpreb#1 mice
exhibited a complete developmental arrest at the im-
Figure 2. Enforced SLC Expression Affects B Cell Develop-
ment
(A) Flow cytometric analysis of total lymphoid fractions in BM, spleen,
mesenteric lymph nodes (LN), and peritoneal cavity (PC) of indicated
mice. Expression profiles of the indicated markers are shown as dot
plots and percentages of cells within the indicated gates are given.
Data shown are representative of 9–11 animals per genotype.
(B) Absolute numbers of total B cell (B220+CD19+), pro-;pre-B cell
(B220+Igm-), immature B cell (B220lowIgm+), and mature B cell
(B220highIgm+) fractions per hind leg. Bars represent average values
and the standard error of the mean (SEM) (3106) of 9–11 animals per
genotype. Total numbers of BM B cells were significantly reduced in
l5#2 and Vpreb#1 (p < 0.02) and in l5#2;Vpreb#1 (p < 0.0001) mice,
when compared with WT mice. Likewise, immature B cell fractions
were reduced in Vpreb#1 (p < 0.002) and l5#2;Vpreb#1 (p < 0.001)
mice and mature B cells in all three groups of SLC mice (p < 0.0001).Immature B cell stage and lacked peripheral B cells
(Figure S1A). Homozygous l5#2;Vpreb#1 mice displayed
uniform, high SLC overexpression in large and small pre-B
cells, both intracellular and at the cell surface (Figure 3C).
Nevertheless, high SLC overexpression did not result
in increased BrdU incorporation in vivo in the large and
small pre-B cell population (Figure 3D). Furthermore,
l5#2;Vpreb#1 heterozygote and homozygote SLC Tg
pre-B cells displayed normal proliferation to IL-7 in vitro,
as determined by [3H]-thymidine incorporation (Fig-
ure 3E). In agreement with this, cell sizes of WT and SLC
Tg pre-B cells were not substantially different (Fig-
ure S1B). Collectively, these findings demonstrate that
enforced SLC expression did not result in increased pre-
B cell proliferation, nor did it affect the generation of small
pre-B cells.
SLC Expression Induces Developmental Arrest
of Immature B Cells
The reduction of immature B cells in the BM of SLC Tg
mice (Figure 2) prompted us to investigate cytoplasmic
and surface IgHC, LC, and SLC expression in these cells.
In WT mice, expression of SLC and kLC was mutually
exclusive in B220low pre-;immature B cell fractions. In
contrast, intracellular and surface coexpression of these
proteins was found in SLC Tg immature B cells (Figures
S2A and S2B). Interestingly, we observed that SLC Tg
B220lowm+k+ immature B cells expressed very low
amounts of BCR on their membrane, despite the abun-
dant presence of intracellular kLC protein (Figure 4A).
This indicates an arrested progression of cytoplasmic
Igklow into surface Igkhigh immature B cells in SLC Tg
mice, in particular in Vpreb#1 and l5#2;Vpreb#1 mice.
Therefore, we characterized the kinetics of the develop-
mental progression of pre-B cells in detail. WT and
l5#2;Vpreb#1 mice were injected with BrdU and the pro-
portions of BrdU+ cells in various B lineage cell fractions
were determined over time (Figure 4B). At 24 hr, the
BrdUproportions in pro-B, large, and small pre-B cell frac-
tions were comparable between WT and l5#2;Vpreb#1
mice. However, in l5#2;Vpreb#1 mice, the proportions
of BrdU+ cells were increased in klow immature B cell frac-
tions (approximately 33%, compared with approximately
23% in the WT) and decreased in khigh immature B cell
fractions (approximately 1%, compared with approxi-
mately 6% in the WT). This impaired progression from
klow into khigh was also observed at 48 and 72 hr and
was accompanied by a dramatic reduction in the total
numbers of BrdU+ B cells that entered the spleen
(Figure S3). Thus, the expression of SLC components
beyond the pre-B cell stage resulted in defective develop-
mental progression in the BM of cytoplasmic klow imma-
ture B cells into surface Igkhigh B cells that are capable
of migrating to the spleen.
Constitutive BCR Internalization in SLC Tg
Immature B Cells
The impaired progression from klow into khigh immature B
cells in SLC Tg mice paralleled the phenotype of Tgmunity 27, 468–480, September 2007 ª2007 Elsevier Inc. 471
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SLC Silencing Avoids Autonomous B Cell ActivationFigure 3. Pre-B Cell Differentiation of SLC Tg Mice
(A) Flow cytometric analysis of B220 and cytoplasmic k on CD19+
gated B cells in BM (top panel). The B220+ck pro-;pre-B cell fractions
were gated and analyzed for cytoplasmic m, CD2, and CD25 expres-472 Immunity 27, 468–480, September 2007 ª2007 Elsevier Incmice with constitutive BCR signaling due to the expres-
sion of the BTKE41K mutant (Maas et al., 1999)
(Figure S4). Therefore, reduced BCR surface expression
on SLC Tg immature B cells might reflect constitutive in-
ternalization of (pre-)BCR molecules, in agreement with
cell-autonomous pre-BCR signaling (Meixlsperger et al.,
2007; Ohnishi and Melchers, 2003). Alternatively, it might
result from the capacity of SLC to obstruct BCR mem-
brane expression. To distinguish between these two pos-
sibilities, we bred l5#2;Vpreb#1 mice with mice deficient
for Slp65, which is essential for pre-BCR signaling and
internalization (Flemming et al., 2003; Jumaa et al., 1999;
Meixlsperger et al., 2007). Analyses of the Igk LC expres-
sion profiles showed that in WT and Slp65-deficient mice,
approximately 54% of the cytoplasmic k+ cells expressed
detectable amounts of kLC on the cell surface (Figure 5A).
This proportion was reduced to approximately 21% in
l5#2;Vpreb#1 mice but restored to approximately 57%
in l5#2;Vpreb#1 Slp65/ mice. These findings show
that SLC components do not obstruct BCR surface ex-
pression (e.g., by competing with conventional LC for
HC pairing), but rather they induce Slp65-dependent con-
stitutive BCR internalization.
Secondary Antibody Gene Rearrangement in SLC
Tg Immature B Cells
The observed BCR internalization and apparent deletion
of SLC Tg immature B cells paralleled the fate of develop-
ing B cells carrying an autoreactive BCR. Because autor-
eactive BCR can induce receptor editing in immature B
cells (Nemazee, 2006), we aimed to explore the extent of
secondary rearrangement of the Igk and Igl loci in SLC
Tg B cells. To this end, we crossed l5#2;Vpreb#1 mice
with 3-83md Tg mice (Russell et al., 1991) harboring
a BCR transgene consisting of prerearranged mHC and
sion. Data are displayed as dot plots, and numbers indicate the
percentages of cells within the quadrants and are representative of
more than five animals per group.
(B) Proliferation of developing B-lineage cells in vivo in WT and
l5#2;Vpreb#1 mice. Mice were intra peritoneal (i.p.) injected with a
single dose BrdU, and after 4 hr, percentages of BrdU+ cells in the BM
B lineage cell fractionswere determined by flow cytometry. Analyzed B
cell population were pro-;large pre-B cell (CD19+CD2ck), small pre-
B cell (CD19+CD2+ck), and immature B cells (CD19+cm+cklow/+). The
average and SEM of three animals per group are shown.
(C) Flow cytometric analysis of intracellular l5 and Vpreb expression in
the large pre-B cell (CD19+cm+CD2) and small pre-B cell
(CD19+ckCD2+) fractions and of membrane l5 and Vpreb expression
on CD19+ck pro-;pre-B cells from WT and mice heterozygote and
homozygote for l5#2;Vpreb#1 Tg. Results are displayed as histo-
grams with overlays of the indicated Tg mice. Plots are representative
for four to five mice of each genotype.
(D) In vivo proliferation of pre-B cells in heterozygous or homozygous
l5#2;Vpreb#1 Tg mice. Four hours after BrdU injection, the percent-
ages of BrdU+ cells in pre-B cell fractions were determined by flow
cytometry. The average and SEM of three animals per group are
shown.
(E) Proliferative responses of total BM cells to IL-7, measured by [3H]-
thymidine incorporation after 4 days of culture. Bars represent average
counts per minute (cpm) values and SEM of 5–11 animals per group..
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body specific for MHC class I H-2Kk,b. On the MHC class
I H2-Kd background, 3-83md Tg mice contain a virtually
monoclonal B cell population bearing the innocuous 3-
83md BCR, recognized by the idiotypic antibody 54.1. In
this system, rearrangements of endogenous Igk and Igl
loci can therefore bemonitored by the loss of 54.1 reactiv-
ity and the induction of Igl LC expression in splenic B
cells. However, in l5#2;Vpreb#1;3-83md mice, B cell
development in the BM was severely hampered and
peripheral B cells were almost completely lacking
(Figure S5A). Therefore, we crossed the low-copy-number
SLC Tg mice l5#1;Vpreb#3 with 3-83md mice. In the
resulting l5#1;Vpreb#3;3-83md mice, approximately
24% of splenic B cells had lost 54.1 reactivity and approx-
Figure 4. Arrested B Cell Development at the Immature B Cell
Stage in SLC Tg Mice
(A) Analysis of surface BCR expression on immature B cells from WT
and SLC Tg mice by flow cytometry. B220lowcm+ pre-;immature B
cell fractions were gated and examined for cytoplasmic (ck) and
surface (Igk) expression (top panel). Cytoplasmic k+ cells were gated
and analyzed for surface Igk. Results are displayed as histogram over-
lays on top of profiles of WT mice (lower panel). Data shown are repre-
sentative of more than six animals per group.
(B) Kinetics of the developmental progression of B lineage cells in the
BM of WT and l5#2;Vpre#1 mice. Mice were injected with a single
dose of BrdU. After 24, 48, or 72 hr, the percentages of BrdU+ cells
in BM B lineage cell fractions were determined by flow cytometry.
Pro-;large pre-B cells were CD19+CD2ck, small pre-B cells were
CD19+CD2+ck, and CD19+CD2+ immature B cells were divided into
cklow and ckhigh fractions. Error bars represent SEM values of n = 3
animals per group, and asterisks indicate statistically significant differ-
ences (p < 0.05).Imimately 9% expressed Igl LC (Figure 5B, compared with
approximately 3% and approximately 1% in 3-83md
mice, respectively). We therefore conclude that the pres-
ence of SLC induced a significant amount of (secondary)
rearrangement of endogenous Ig LC loci.
The deletion of autoreactive immature B cells can be
rescued by the anti-apoptotic protein Bcl2. Consistent
with this, we found that in l5#2;Vpreb#1 mice carrying
the Em-Bcl2 transgene (Strasser et al., 1991), immature
B cells exhibited increased survival, allowing the develop-
ment of IgM+IgD+ B cells, which were virtually absent in
l5#2;Vpreb#1 mice (Figure 5C). In addition, Bcl2 is
assumed to provide an extended time window per cell
for secondary rearrangement of the Igk and Igl gene loci,
and because the Igk and Igl loci are sequentially activated
for V to J recombination, the enforced expression of Bcl2
results in elevated l usage (Lang et al., 1997). Accordingly,
we found that in Em-Bcl2 mice, approximately 34% of
surface IgLC+B220low immature B cells were Igl+ (com-
pared with approximately 9% in WT mice). Interestingly,
l usage in l5#2;Vpreb#1;Em-Bcl2 mice was increased to
approximately 59% of the total IgLC+B220low fraction, in-
dicating that Tg SLC enhanced secondary antibody gene
rearrangement.
Taken together, these data show that SLC proteins sig-
nal for Slp65-dependent BCR internalization in immature
B cells, resulting in a developmental arrest at this stage,
accompanied by increased receptor editing.
Constitutive Activation of SLC Tg Splenic B Cells
In SLC Tg mice, the majority of splenic B cells coex-
pressed IgHC, IgLC, and SLCs on the cell surface
(Figure 1D), but nevertheless, substantial fractions of
IgMlowIgDlow cells were present (approximately 17%–
20%, compared with less than 5% in the WT, Figure 6A),
suggesting BCR activation. Accordingly, we noticed slight
increases in the proportions of CD69+-activated B cells
and in forward scatter values, reflecting increased aver-
age B cell size (Figure 6A). Detailed analysis of CD19+
splenic B cells in SLC Tg mice revealed a relative increase
in the CD23low B cell fractions, which normally include
CD21 immature B cells andCD21highmarginal zone cells.
However, in SLC Tg mice, the CD23low B cell fraction
mainly consisted of B220lowCD5+ B-1-like B cells (approx-
imately 23%–38% of splenic B cells), which in WT mice
comprise only a small fraction of splenic B cells. Because
of a concomitant reduction in total spleen cellularity, the
absolute numbers of CD5 B cells in SLC Tg mice were
dramatically low (1–53 106 cells, compared with approx-
imately 453 106 cells in WT mice) (Figure 6B). In contrast,
the CD5+ B cell population was only mildly affected, with
an approximately 50% reduction in the l5#2;Vpreb#1
compared to WT mice. The effects of SLC expression on
mature B cells were dose dependent: Low-expressing
l5#1;Vpreb#3 Tg mice did not exhibit reduced splenic B
cell numbers, but when they were bred to homozygosity,
we observed reduced numbers of splenic B cells, in-
creased average B cell sizes, a slight increase in the
proportions of B220lowCD5+ B cells, and a substantialmunity 27, 468–480, September 2007 ª2007 Elsevier Inc. 473
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Internalization and Secondary Ig LC Rearrangement in Imma-
ture B Cells
(A) Analysis of surface BCR expression on immature B cells from the
indicated mouse groups by flow cytometry. Cytoplasmic and surface
k expression was determined in the B220lowcm+ pre-;immature B cell
fractions (top panel). Subsequently, cytoplasmic k+ cells were gated
and analyzed for surface Igk. Results are displayed as histogram over-
lays on top of profiles of WT mice (lower panel). Data shown are repre-
sentative of more than four animals per group.
(B) Flow cytometric analysis of splenic lymphoid populations of 3-83md
Tg and low-copy-number l5#1;Vpreb#3;3-83md Tg mice. Numbers
indicate percentages of Igm+Igd+ B cells within the total lymphoid frac-
tions (upper panel). CD19+ cells were gated and analyzed for surface474 Immunity 27, 468–480, September 2007 ª2007 Elsevier Incinduction of CD21hiCD23low marginal zone B cells
(Figure S5B). The findings in l5#2, Vpreb#1, and
l5#2;Vpreb#1 mice of (1) relatively increased CD5+ B
cell populations, which are known for their self-reactive
BCR repertoire (Hayakawa et al., 1999), (2) increased
average B cell sizes, and (3) a relative increase in CD69+
and surface BCRlow B cells suggested that SLC Tg splenic
B cells received signals that mimicked BCR activation. To
directly investigate whether Tg SLC induced constitutive
Igm internalization in splenic B cells, we labeled surface
Igm HCs with biotinylated Fab’ fragments (thereby avoid-
ing BCR crosslinking), and we followed surface Igm
expression over time (Figure S6A). We found significantly
(p < 0.025) increased constitutive Igm internalization in
l5#2;Vpreb#1 CD5 B cells, when compared with WT B
cells (which were about 95% CD5) (Figure 6D). Consis-
tent with a role for CD5 as a negative regulator of BCR sig-
naling, l5#2;Vpreb#1 CD5+ B cells manifested decreased
constitutive Igm internalization (Figure 6D). As a control, we
observed normal Igm internalization upon BCR crosslink-
ing with biotinylated F(ab’)2 fragments for l5#2;Vpreb#1
splenic B cells (Figure 6E and Figure S6B). Nevertheless,
the analysis of unstimulated and anti-IgM-stimulated
splenic B cells by immunoblot analysis with phosphotyro-
sine-specific antibodies demonstrated that l5#2;Vpreb#1
B cells have impaired BCR-induced phosphorylation
(Figure 6C). In agreement with this finding, SLC Tg mature
B cells manifested reduced in vitro responses to anti-IgM
stimulation, indicating an increased tolerance for BCR
stimulation, typical for anergic B cells (Melchers, 2006)
(Figure S7).
Collectively, the observed constitutive Igm internaliza-
tion shows that SLC expression in mature B cells
enhanced constitutive (pre-)BCR internalization but did
not interfere with ligand-mediated Igm internalization.
Nevertheless, the response of SLC Tg B cells to BCR-
engagement in vitro was severely reduced.
Increased IgM+ Plasma Cell Formation in SLC
Tg Mice
The immunohistochemical analysis of l5#2;Vpreb#1
spleens confirmed the reduction of B cell numbers and
revealed normal B and T cell organization, as well as the
presence of dramatically increased numbers of IgMhigh
cells (Figure 7A). Based on increased numbers of
cm+CD138+ cells (up to 40% of all cm+ cells in
l5#2;Vpreb#1, compared with approximately 1% in WT
mice) and IgM antibody-secreting cells (ASC) in an
expression of 54-1 idiotype 3-83md BCR and Igl (lower panel). Per-
centages of cells within the quadrants are given, and the data shown
are representative of more than three animals per group.
(C) Flow cytometric analysis of specified surface markers in BM and
spleen from the indicated four groups of mice. The top panel shows
B220,Igm profiles of gated total lymphoid BM fractions. Total B cell
fractions (CD19+B220+) and immature B cell fraction (CD19+B220low)
were gated and analyzed for Igm,Igd or Igk,Igl profiles, respectively.
Total splenic lymphoid compartments were examined for CD19 and
Igm expression. Data shown are representative of more than five
animals per group..
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Spleen
(A) Analysis of splenic B cells of SLC Tgmice by flow cytometry. CD19+
B cells were gated and analyzed for the indicated markers; results are
displayed as dot plots or histogram overlays on top of profiles of WT
mice. The given numbers represent the percentages of gated cells
within total CD19+ B cell population. Data shown are representative
of move than six animals per group.Immenzyme-linked immunosorbent spot (ELISPOT) assay
(Figures 7B–7D), we concluded that these IgMhigh cells
in the spleen were plasma cells. SLC Tgmice did not man-
ifest substantially increased numbers IgM+ ASC in the BM,
but nevertheless serum IgM concentrations were 2-fold to
3-fold increased, as determined by enzyme-linked immu-
nosorbent assay (ELISA) (Figure 7E). Other Ig isotypes
were variable between individual mice, but most IgG sub-
classes amounts were significantly reduced in l5#2 and
l5#2;Vpreb#1 mice. In ELISPOT and ELISA assays, we
did not detect substantial secretion of SLC components,
probably reflecting the observed reduced SLC expression
(which is controlled by the CD19 promoter) and increased
conventional LC expression in CD138+ plasma cells.
To investigate mature B cell function, we determined B
cell responses to T cell-independent type II (TI-II) and T
cell-dependent (TD) antigens in vivo (Figures 7F and 7G).
Upon immunization with the TI-II antigen TNP-Ficoll,
l5#2;Vpreb#1 mice had lower serum amounts of TNP-
specific IgM and IgG3, compared with WT mice. l5#2 or
Vpreb#1 single-Tg mice had normal TNP-specific IgM
and increased IgG3 concentration. Upon immunization
with the TD antigen TNP-KLH, serum of SLC Tgmice con-
tained higher amounts of TNP-specific IgM. In contrast,
amounts of TNP-specific IgG1 or IgG2b were decreased
in l5#2 or Vpreb#1 single-Tg mice and virtually absent in
l5#2;Vpreb#1 double-Tg mice. Furthermore, immunohis-
tochemical analyses of the spleen 7 days after immuniza-
tion revealed that in l5#2;Vpreb#1 mice, the size and
numbers of PNA+ germinal centers (GC) and the numbers
of IgG1 plasma cells were reduced (Figure 7H).
Taken together, these analyses show that in the pres-
ence of Tg SLC the mature B cells present were efficiently
activated for differentiation into IgM+ plasma cells,
whereby germinal-center formation and class switch
recombination were hampered.
DISCUSSION
The pre-BCR is transiently expressed on the cell surface
of large cycling pre-B cells and induces proliferation,
followed by the downregulation of the SLC components
and differentiation into small resting pre-B cells (Melchers,
2005). A key finding in our study is the demonstration that
(B) Absolute numbers of CD5 and CD5+ B cells per spleen (average
and SEM of more than six animals per group) in the four groups of
mice. Asterisks show statistically significant differences (p < 0.01)
within the CD5+ population.
(C) Examination of protein tyrosine phosphorylation in extracts of
untreated and anti-IgM treated WT and l5#2;Vpreb#1 purified splenic
B cells, analyzed by immunoblot analysis with a phosphotyrosine (pY)-
specific antibody. The membrane was reblotted with anti-Erk1,2 as
a loading control.
(D and E) Kinetics of the constitutive (D) and ligand-mediated (E) Igm
internalization by WT total splenic B cells and l5#2;Vpreb#1 CD5
andCD5+ B cells determined with anti-Igm Fab’ and anti-Igm F(ab’)2, re-
spectively. Constitutive Igm internalization by l5#2;Vpreb#1 CD5 B
cells was significantly (p < 0.025) increased from T = 3 min onward,
when compared with WT B cells. Data shown are average values ±
SEM of six WT and five l5#2;Vpreb#1 mice.unity 27, 468–480, September 2007 ª2007 Elsevier Inc. 475
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SLC Silencing Avoids Autonomous B Cell ActivationFigure 7. Increased IgM+ Plasma Cell Formation and Altered In Vivo Ig Subclass Production in SLC Tg Mice
(A) Immunohistochemical analysis of IgM (brown, for IgM+ B cells and plasma cells) and MOMA1 (blue, staining metallophillic marginal zone macro-
phages) in spleen of the indicated mice.
(B) Splenic cytoplasmic m+ cells were analyzed for the cytoplasmic mHC and surface CD138. Numbers indicate the percentages of cm+CD138- B cells
and cmhighC138+ plasma cells within cm+ splenic cell population. Data shown are representative of more than six animals per group.
(C) Percentages of splenic IgM+ plasma cells (gated as cmhighCD138+) within in the total splenic cm+ cell population in WT and SLC Tg mice. Each
symbol indicates an individual animal; asterisks indicate significant differences (p < 0.05).
(D) Numbers of IgM-producing cells per 105 cells in spleen and BM, determined by ELISPOT assay for the indicated genotypes. Each symbol
indicates one individual animal.
(E) Serum concentration of Ig subclasses in indicatedmice, determined by ELISA. Each symbol indicates an individual animal. IgM concentration was
significantly increased in l5#2 (p < 0.025), Vpreb#1 (p < 0.04) and l5#2;Vpreb#1 (p < 0.015) mice, when compared to WT. IgG1 concentration was
decreased in l5#2 (p < 0.006) and l5#2;Vpreb#1 (p < 0.0002) mice, when compared to WT. Likewise, IgG3 concentration was reduced in l5#2 (p <
0.005) and l5#2;Vpreb#1 (p < 0.00001) mice.
(F) TI-II immune responses, determined by ELISA for TNP-specific IgM and IgG3 antibodies, 7 days after TNP-Ficoll injection. Each point represents
the mean optical density of three to five mice per group.
(G) TD immune responses, determined 7 days after TNP-KLH booster. Each point represents the mean optical density of three to five mice per group.
(H) Immunohistochemical analysis of WT and l5#2;Vpreb#1 spleen, 7 days after TNP-KLH booster. Sections were stained with anti-IgD (blue), PNA
(brown, indicated by arrow head) for germinal center (GC) B cells, anti-IgM (brown) for IgM+ B cells and plasma cells, MOMA1 (blue) for stainingmetal-
lophillic marginal zone macrophages, and anti-IgG1 (blue) for IgG1
+ GC B cells and plasma cells.the continuation of SLC expression beyond the large
cycling pre-B cell stage did not induce enhanced prolifer-
ation. Our data argue against the notion that pre-B cells
become resting because SLC proteins are diluted out476 Immunity 27, 468–480, September 2007 ª2007 Elsevier Incand show that the ability of SLC to induce proliferation is
context dependent: SLC only supports cellular prolifera-
tion at the IL-7R+CD2CD43+ large cycling pre-B cell
stage..
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in vivo and in vitro is in strong contrast with the approxi-
mately 10-fold to 15-fold increased in vitro expansion of
Btk/ or Slp65/ pre-B cells, which fail to downregulate
SLC (Kersseboom et al., 2003; Middendorp et al., 2002).
Because Btk/ or Slp65/ pre-B cells do not terminate
IL-7R expression upon pre-BCR signaling (Kersseboom
et al., 2003; Schebesta et al., 2002), we propose that
increased IL-7 responsiveness, rather than high surface
pre-BCR expression, enhances proliferation of Btk/ or
Slp65/ pre-B cells. Because SLC Tg large pre-B cells
still lose their proliferative capacity upon pre-BCR signal-
ing, we conclude that pre-B cell proliferation is most likely
terminated by the downregulation of IL-7 responsiveness.
Accordingly, SLC Tg mice did not develop pre-B cell
tumors, nor did Tg SLC expression increase pre-B cell
leukemia incidence in Slp65/ mice (P.F.v.L., unpub-
lished data).
Sustained SLC expression beyond the pre-B cell stage
did not induce proliferation of BCR-expressing cells, but
nevertheless hampered the progression from surface
IgMlow into IgMhigh immature B cells in the BM. In particu-
lar, the SLC proteins, which mediate constitutive receptor
signaling (Meixlsperger et al., 2007; Ohnishi andMelchers,
2003), induced constitutive BCR internalization, second-
ary Ig LC rearrangement, and substantial deletion. In
SLC Tg immature B cells, Vpreb expression was higher
than that present in WT pro-B or pre-B cells. Thus, it might
be argued that the developmental arrest of immature B
cells resulted from unspecific effects, such as the capacity
of SLC overexpression to obstruct BCR membrane
expression or to induce ER responses. However, we
found that in the absence of Slp65, SLC Tg immature B
cells were able to progress from the IgMlow into the IgMhigh
stage, implicating that Tg SLC proteins specifically acti-
vated Slp65-dependent (pre-)BCR signaling pathways.
Our data show that SLC-mediated signaling interfered
with basal BCR signaling required for the development
and survival of B cells (Tze et al., 2005) and that conven-
tional LCs in immature B cells were unable to inhibit auton-
omous pre-BCR signaling. The finding that peripheral B
cells were lacking in homozygous l5#2;Vpreb#1 mice
and in l5#2;Vpreb#1;3-83md Tg mice indicates that the
extent of B cell deletion is dependent on LC to SLC ratio,
as well as BCR specificity.
Unexpectedly, l5 and Vpreb were expressed on the cell
surface independent of each other (Minegishi et al., 1999;
Seidl et al., 2001). Moreover, SLC single- and double-Tg
mice manifested parallel phenotypes, including defective
surface BCR expression on immature B cells in the BM,
increased activation of mature splenic B cells, and en-
hanced plasma cell development. Interestingly, also the
effect of Vpreb on surface BCR expression on immature
B cells was Slp65 dependent (P.F.v.L., unpublished
data). Taken together, these findings imply that not only
the non-Ig domain of l5 (Ohnishi and Melchers, 2003)
but also Vpreb has the capacity to induce constitutive
(pre-)BCR signaling, at least in the presence of conven-
tional LC. Further experiments are required to identifyImthe molecular mechanism by which Vpreb can induce
the activation of (pre-)BCR signaling pathways in the
absence of l5.
Despite increased constitutive BCR internalization, sur-
face BCR expression on l5#2;Vpreb#1 Tg splenic B cells
was remarkably restored, when compared with immature
B cells in the BM. Several mechanismsmight contribute to
the rescue of surface BCR expression on splenic B cells.
First, these cells express high amounts of IgLC, resulting
in a more favorable LC to SLC ratio. Second, mature B
cells are less sensitive to BCR stimulation, requiring
approximately 10-fold higher antigen amounts for Ca2+
fluxes (Wen et al., 2005) than immature B cells do. Third,
because of the developmental arrest of immature B cells,
only B cells with distinctive signaling properties, e.g., low-
affinity BCR, might be selected to enter the periphery.
Fourth, the expression of CD5, which is a negative regula-
tor of BCR signaling (Hippen et al., 2000), will limit the
effects of SLC. Finally, interactions with stromal cells,
which are reported to enhance pre-BCR signaling in the
BM signaling (Bradl and Jack, 2001; Gauthier et al.,
2002), might be absent in the splenic microenvironment.
Studies in mice demonstrated that B-1 and marginal
zone B cells are positively selected by self antigens (Hay-
akawa et al., 1999; Lam et al., 1997; Tze et al., 2005; Wen
et al., 2005). Using mice Tg for the constitutive active BCR
surrogate Epstein-Barr virus protein LMP2A (Casola et al.,
2004) or for a BCR recognizing the self antigen Thy1
(CD90) (Wen et al., 2005), it was demonstrated that in-
creasing BCR signaling strength directed developing B
cells from the default follicular B cell fate into the marginal
zone B cell and eventually into the B-1 cell lineage. This is
paralleled by the dose-dependent effect of SLC on mar-
ginal zone and CD5+ B cell development, consistent with
the notion that SLC increases basal BCR signaling.
The influence of SLC on antigen-dependent BCR sig-
naling appears less straightforward. On the one hand, the
findings that SLC Tg splenic B cells are refractory to BCR
stimulation in vitro and have low TI-II responses in vivo
argue for an inhibitory effect of SLC on antigen-dependent
BCR signaling. On the other hand, a stimulatory effect is
supported by the spontaneous IgM+ plasma cell differen-
tiation and increased TD IgM responses in vivo. It is con-
ceivable that SLC expression and the associated continu-
ous receptor signaling render peripheral B cells anergic
(Gauld et al., 2005; Hippen et al., 2000). Indeed, mature
SLC Tg B cells are short lived, do not recirculate, express
substantial amounts of CD5, are refractory to BCR stimu-
lation, and are rescued from anergy if antigen stimulated
together with adequate T cell help (Cyster et al., 1994).
The TD immune responses in SLC Tgmice showed limited
germinal-center formation and HC class switch recombi-
nation, paralleling features of anergic or B-1 cells, which
are unable to effectively participate in germinal center re-
sponses. Unlike anergic B cells, SLC Tg B cells do not ex-
press reduced surface BCR expression, but it is possible
that those B cells that have escaped central deletion carry
a very low-affinity BCR or have become hyporesponsive
because of constitutive (pre-)BCR signaling (leading tomunity 27, 468–480, September 2007 ª2007 Elsevier Inc. 477
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ways, in line with the reported lack of Ca2+ influx after pro-
longed pre-BCR signaling) (Meixlsperger et al., 2007).
A considerable fraction of the plasma cells in SLC Tg
mice produced self-reactive antibodies because we de-
tected elevated amounts of anti-nucleosome IgM in the
serum (P.F.v.L, unpublished data). In this context, SLC
Tg B cells resemble the small subset of human circulating
SLC+ B cells, which escape tolerance mechanism and
express self-reactive antibodies (Meffre et al., 2004). Inter-
estingly, these B cells display an unusual IgHC and IgLC
repertoire with evidence for extensive receptor editing.
Thus, our findings that sustained SLC expression is asso-
ciatedwith spontaneous plasma cell development and au-
toantibody formation suggest a possible primary involve-
ment of SLC dysregulation in the etiology of autoimmunity.
In summary, in this report we have shown that Tg
expression of SLC components throughout B cell devel-
opment (1) does not affect pre-B cell proliferation and
differentiation, (2) results in secondary antibody gene rear-
rangements and the deletion of immature B cells, and (3)
induces constitutive BCR signaling and the activation of
mature B cells, thereby driving these cells effectively into
IgM+ plasma cell differentiation. Because we demonstrate
that constitutive pre-BCR signaling is not sufficient to
drive proliferation, our findings have important implica-
tions for our view on the regulation of proliferation at the
pre-B cell receptor checkpoint. Furthermore, exploring
the dose-dependent effects of SLC components on reper-
toire selection should help us to understand how in auto-
immune disorders B cells can escape central tolerance
mechanisms and express self-reactive antibodies.
EXPERIMENTAL PROCEDURES
Generation of Mice and Genotyping
A 4.2 kb BglII-PstI Igll1 (l5) fragment (a BglII site is 58 bp upstream of
the ATG in exon 1 and a PstI site is located 30 of exon 3) and a 1.5 kb
PvuII-BglII Vpreb1 fragment (a PvuII site is located 57 upstream of the
ATG and a BglII site is located 30 of exon 2) were each ligated to
a 6.3 kb Eagl-HpaII genomic human CD19 promoter fragment. The
HpaII site in exon 1 of the CD19 gene is located 16 bp upstream of
the ATG start site. CD19-l5 and CD19-Vpreb constructs (Figure 1)
were separately injected into pronuclei of FVB fertilized oocytes and
implanted in pseudopregnant foster mice. The genotype of the
founders was determined by Southern blotting. For CD19-l5 Tg,
EcoRV-digested tail DNA was hybridized with a BglII-SphI fragment
from the CD19-l5 construct as a probe. For CD19-Vpreb Tg, PstI
digested tail DNA was hybridized with a BamHI-EcoRI fragment from
the CD19-Vpreb construct. Next generations of SLC Tg mice, as well
as CD19-hBTKE41K (Kersseboom et al., 2003; Maas et al., 1999),
Slp65/ (Jumaa et al., 1999), 3-83md (Russell et al., 1991), and
Em-Bcl-2-22 (Strasser et al., 1991) mice were genotyped by polymer-
ase chain reaction (PCR). Mice were bred and maintained at the Eras-
mus MC animal care facility under specific pathogen-free conditions
and were analyzed at the age of 6–12 weeks. Experimental procedures
used in this studywere reviewed and approved by the ErasmusUniver-
sity Committee of Animal Experiments.
Pre-B and B Cell Cultures
The in vitro IL-7 responsiveness of BM B cells were determined as
described previously (Middendorp et al., 2002). For the analysis of the
response of splenic B cell to anti-IgM and lipopolysaccharide (LPS),478 Immunity 27, 468–480, September 2007 ª2007 Elsevier Incspleen suspensions were depleted from erythrocytes by standard
NH4Cl lysis and cultured at a concentration of 2 3 10
6 cells/ml with
10 mg/ml anti-IgM (1020-01, ITK) or 10 mg/ml LPS.
Flow Cytometric Analysis
Analysis was performed as described previously (Middendorp et al.,
2002). The anti-38-3md hybridoma 54-1 was kindly provided by
D. Nemazee (Scrips Research Institute [La Jolla, CA]). Events (1–5 3
105) were scored with a FACSCalibur flow cytometer and analyzed
by CellQuest software (BD Biosciences). In vivo BrdU-labeling was
performed as previously described (Middendorp et al., 2002).
BCR Internalization
Splenic cell suspensions were preincubated at 4C for 30 min in RPMI
with 0.5% fetal calf serum (FCS) and 1 mg/106 cells goat anti-mouse-
IgM-Fab’ or goat anti-mouse IgM-F(ab’)2, out of which 40%were biotin
conjugated (Jackson ImmunoResearch). Subsequently, cell suspen-
sions were washed to remove free anti-IgM Fab’ or F(ab’)2 fragments,
incubated at 37C, and after the indicated time points, cells were
immediately fixed with 1% paraformaldehyde in phosphate-buffered
saline (PBS) for 2 min on ice and 20 min at room temperature (RT).
BCR internalization wasmade visible by flow cytometry after a second-
ary staining stepwithmAbs to B220, CD5, CD19, and APC-conjugated
streptavidin for the visualization of surface IgM. Percentages of in-
ternalization were calculated as (MFI-sIgM[T0] – MFI-sIgM[Tn])/MFI-
sIgM[T0] 3 100.
ELISPOT Assay, Serum Ig Detection, and Immunization
In Vivo
ELISPOT assays were performed with standard procedures. In brief,
multiscreen nitrocellulose filtration plates (MAHAN 4550, Millipore)
were filled with cell suspensions (100 ml/well) in a dilution range of
1/3, starting with 105 cells/well and incubated at 37C for 3 hr. Se-
creted IgM was visualized by subsequent incubations with a biotiny-
lated IgM-specific antibody (1020-08, Southern Biotechnology Associ-
ates), streptavidin-coupled peroxidase (016-030-084 Jackson
ImmunoResearch), and 3-amino-9-ethylcarbazole (A5754, Sigma) as
a substrate. Spots (ASC) were counted by lightmicroscopy. Immuniza-
tions and isotype-specific ELISA for total and TNP-specific Ig have
been described previously (Dingjan et al., 1998).
Immunoblot Analysis
B lineage cells, purified from spleen by AutoMACS with anti-B220
microbeads (130-049-501, Miltenyi) according to standard proce-
dures, were stimulated with 10 mg/ml goat anti-mouse-IgM F(ab’)2
(115-006-075, Jackson ImmunoResearch) in RPMI at 37C for 5 min.
Immunoblotting (Kersseboom et al., 2003) was performed with anti-
phosphotyrosine P-Tyr-100 (9411, Cell Signaling Technology) and
anti-Erk1/2 (SC-094, Santa Cruz Biotechnology).
Immunohistochemistry
Preparation of 6 mm cryostat sections and double labelings were per-
formed according to previously described procedures (Dingjan et al.,
1998). The primary antibodies used were MOMA1 (kindly provided
by G. Kraal, VU University Medical Center [Amsterdam]); anti-IgD
(L1120-09, Southern Biotechnology Associates); biotinylated anti-
IgM (02202D BD PharMingen), anti-IgG1 (02234D, BD PharMingen),
and biotinylated PNA (Sigma).
Statistical Analysis
Significances of differences between experimental values were deter-
mined by a paired Student’s t test.
Supplemental Data
Seven figures and one table are available at http://www.immunity.
com/cgi/content/full/27/3/468/DC1/..
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